Episode 1049: How META Weaponized Scale AI's $15B Valuation, Intel Lying About Demand, Moderna

Martin Shkreli (0:00)

Volatility gives you those like chances to like trade your way out of these things. If you're just short and like you're short a million shares, and you got to sit in there, you can't get out of it, you know, you don't have the opportunity to like dart in and out through 25,000 shares or something like that, which is like more our size. I'm not trading a million, million shares. I don't know if he's trading breakouts exactly. He can tell you his philosophy a little bit better. I'm not even sure what his process is. I mean, I give him the basic background of like what's going on with the companies. He's definitely reading the news and understanding like the play of the companies, not just the price action for you, or is it mostly the price action?

Keith (0:34)

News and stuff, but mostly price.

Martin Shkreli (0:37)

Okay, so if it was a random ticker, you would be able to mostly still do what you're doing. Okay, interesting.

Keith (0:43)

Some of it, no.

Martin Shkreli (0:44)

You don't think so? No.

Keith (0:46)

Okay. Just give me like something randomly biotic, something that I can try and see.

Martin Shkreli (0:51)

Okay, well, so we'll see how long that lasts. For now, it works. Does Keith have a Twitter account they want to follow you? Well, Chris is a big, I'm sorry. HEE is a big space. I don't know that they killed them, but I don't have a huge position. I need new ideas for sure. Like, we got some nice profits and various, like the Dario dump was probably our best profit. And then even today, in Akamai, that was great. We've had a bunch of good luck, and Moderna has been particularly good to us.

It's like shocking, because it's been such a... We made money on the long side, and then we made money on the short side, and it's just more or less been printing it for us. I mean, right now, we're down on it, but we're just 190 something, so it's not so bad. Yeah, so just to take advantage of relatively short-term opportunities has worked. I don't use Value Line, but I've used it in the past. Set of Kinetics, dumping hard. Is that like a hedge fund hotel? I would buy that. I like Set of Kinetics.

Thank you for that. I wonder how their prescription trends are going. They are launching a drug.

Keith (1:52)

Cure this company.

Martin Shkreli (1:54)

Which one?

Keith (1:55)

They recently did $9 billion. It was $24.

Martin Shkreli (1:59)

Acomy?

Keith (2:00)

Acomy.

Martin Shkreli (2:01)

The stuff we shorted this morning?

Keith (2:03)

What?

Martin Shkreli (2:03)

That's all I talked about this morning. AKA, I'm looking at it on our screen.

Keith (2:06)

Okay, yeah.

Martin Shkreli (2:07)

You remember when I was cheering?

Keith (2:09)

Yes.

Martin Shkreli (2:09)

Okay, that was the stuff. Yeah, what's your question?

Keith (2:11)

There's two sections in the Assets. It says Markle, Secureless, Markle, Secureless, and Secureless.

Martin Shkreli (2:17)

Yeah, so current Assets means Assets that will be liquefied within a year or mature within a year. So like a bond to the government that the government pays back the bond. And then long-term Assets are Assets that have usually like a useful life of over one year. That's like the typical difference. So current Assets are all things that will convert to cash within a year. And everything after current Assets is one is they have a useful life of more than one year.

Keith (2:43)

Yeah.

Martin Shkreli (2:43)

So any property, plant and equipment, things like that. Akamai is a software company, by the way, not a semi-company.

Keith (2:49)

Software security, in a sense.

Martin Shkreli (2:50)

Yeah, software. It's either software or hardware.

Keith (2:53)

Yeah, the software, yeah, that's his thing.

Martin Shkreli (2:56)

Yeah, it's not Sammy's. Yeah, I still want to do Optical. I can't do it. Well, they're jealous, because a lot of them are, they know financial statements really well.

They're like, how come he gets to trade? Like, there's people who just want to be an analyst. They don't want to do any trades. They just want to do research for me, let alone trading a portfolio. That's like, how the f*** did he get that job? There's a couple of things that you don't know.

Keith has AIDS. And this was his make-a-wish. Just kidding. We got to get Hunter on this thing all the time.

Keith (3:27)

This road, it's all, he's like...

Martin Shkreli (3:29)

People would love him. That's how we find his wife.

Keith (3:32)

You're right.